Publication Name	World Journal of Gastroenterology
Manuscript ID	6078
Country	Italy

Received	2013-10-01 19:18
Peer-Review Started	2013-10-01 21:16
To Make the First Decision	2013-10-29 12:37
Return for Revision	2013-10-29 18:57
Revised
Second Decision	2013-11-29 10:56
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2013-11-29 23:58
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2013-12-17 10:10
Publish the Manuscript Online	2014-01-14 20:11

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Transplantation
Manuscript Type	Topic Highlights
Article Title	Transplant benefit for patients with hepatocellular carcinoma
Manuscript Source	Invited Manuscript
All Author List	Alessandro Vitale, Michael Volk and Umberto Cillo
Funding Agency and Grant Number
Corresponding Author	Alessandro Vitale, MD, PhD, Unit?di Chirurgia Epatobiliare e Trapianto Epatico, Azienda Ospedaliera-Universit?di Padova, Via Giustiniani 2, 35128 Padova, Italy. alessandro.vitale@unipd.it
Key Words	Hepatocellular carcinoma; Deceased donor liver transplantation; Living donor liver transplantation; Transplant benefit; Utility; Urgency; Intention-to-treat survival; Harm
Core Tip	Deciding upon the best option for a patient with hepatocellular carcinoma is complicated, involving numerous ethical principles including: urgency, utility, intention-to-treat survival, transplant benefit, harm to candidates on waiting list, and harm to living donors. In this paper we suggest that allocating organs by transplant benefit could help balance these competing principles, and also introduce equity between patients with hepatocellular carcinoma and those with nonmalignant liver disease. We also propose a triangular equipoise model to help decide between deceased donor liver transplantation, living donor liver transplantation, or alternative therapies.
Publish Date	2014-01-14 20:11
Citation	Vitale A, Volk M, Cillo U. Transplant benefit for patients with hepatocellular carcinoma. World J Gastroenterol 2013; 19(48): 9183-9188
URL	http://www.wjgnet.com/1007-9327/full/v19/i48/9183.htm
DOI	http://dx.doi.org/10.3748/wjg.v19.i48.9183

Full Article (PDF)	WJG-19-9183.pdf
Manuscript File	6078-Review.doc
Answering Reviewers	6078-Answering reviews.pdf
Copyright License Agreement	6078-Copyright assignment.pdf
Peer-review Report	6078-Peer review(s).pdf
Scientific Editor Work List	6078-Scientific editor work list.doc